首站-论文投稿智能助手
期刊详情
《国际皮肤性病学杂志(英文)》
主要栏目论著 研究报道 综述
{{ isqkjj == false ? "展开" : "收起" }}
出版周期:季刊
语种:英文
影响因子:0.03
国内刊号:32-1880/R
国际刊号:2096-5540
♦ 主要栏目:
♦ 获奖情况:
♦ 收录情况: {{ e.split(":")[0] }} < 查看更新情况
♦ 期刊情况:CSTPCD
♦ 主管单位:国家卫生健康委员会
♦ 主办单位:中华医学会
联系方式
主编:王宝玺
电话:86-25-85478144
邮编:100052
邮箱:ijdv@cmaph.org
地址:江苏省南京市玄武区蒋王庙街12号
发文分析
发文类型:
{{ obj.kz7 == 1 ? "学术" : obj.kz7 == 2 ? "学术+科普" : obj.kz7 == 3 ? "科普" : "未知" }}
年刊文量:
{{ obj.wznum }}篇
单期页码:
{{ obj.maxpage }}页
发文地域:
{{ item.name }}({{ (item.bl * 100).toFixed(2) }}%)
机构特征:
{{ item.word }}
发文热门词:
{{ item.name }}
文章分类:
{{ item.key }}({{ (item.value * 100).toFixed(2) }}%)
{{ iswzfl == false ? "展开更多" : "收起全部" }}
{{ item.flname }}[{{ item.name }}]({{ (item.bl * 100).toFixed(2) }}%)
Laboratory Safety of Dupilumab, and Its Effect on Inflammatory Biomarkers, in Chinese Adults With Moderate-to-Severe Atopic Dermatitis: An Analysis of a Randomized, Double-Blind Phase III Study
Zhao Yan;Wu Li-Ming;Lu Qian-Jin;Gao Xing-Hua;Zhu Xiao-Hong;Yao Xu;Li Lin-Feng;Li Wei;Ding Yang-Feng;Song Zhi-Qiang;Liu Ling-Ling;Dang Ning-Ning;Zhang Chun-Lei;Liu Xiao-Ming;Gu Jun;Wang Jin-Yan;Geng Song-Mei;Liu Quan-Zhong;Guo Yi-Feng;Dong Li;Li Shelley;Xu Christine;O’Malley John T.;Laws Elizabeth;Amin Nikhil;Bansal Ashish;Wang Min;Zhang Jian-Zhong - Department of Dermatology, Peking University People’s Hospital, Beijing 100044, China;Hangzhou First People’s Hospital, Hangzhou, Zhejiang 310006, China;The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China;The First Hospital of China Medical University, Shenyang, Liaoning 110001, China;Wuxi Second People’s Hospital, Wuxi, Jiangsu 214002, China;Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210042, China;Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Huashan Hospital, Fudan University, Shanghai 200040, China;Shanghai Skin Disease Hospital, Shanghai 200040, China;The Southwest Hospital of AMU, Chongqing 400038, China;Peking University First Hospital, Beijing 100034, China;Jinan Central Hospital, Jinan, Shandong 250013, China;Peking University Third Hospital, Beijing 100191, China;University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong 518040, China;Changhai Hospital of Shanghai, Shanghai 200433, China;Ningbo No. 2 Hospital, Ningbo, Zhejiang 315099, China;The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710004, China;Tianjin Medical University General Hospital, Tianjin 300052, China;Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China;Research & Development, Sanofi, Bridgewater, NJ 08807, USA; Development, Regeneron, Tarrytown, NY 10591, USA;Medical, Sanofi China, Shanghai 200040, China
Efficacy and Safety of Ixekizumab in Chinese Patients With Moderate-to-Severe Plaque Psoriasis: 60-Week Results From a Phase 3 Study
Li Xia;Zheng Jie;Pan Wei-Li;Zheng Min;Lu Yan;Li Fu-Qiu;Ding Yang-Feng;Zhang Jian-Zhong;Li Hong-Ying;Rui Wen-Long - Department of Dermatology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, China;Department of Dermatology, Zhejiang Provincial People’s Hospital, Hangzhou, Zhejiang 314408, China;Department of Dermatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China;Department of Dermatology, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China;Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai 130041, China;Department of Dermatology, Peking University People’s Hospital, Beijing 130041, China;China Drug Development and Medical Affairs Center, Eli Lilly and Company, Shanghai 200041, China
学者H指数区间
机构H指数区间
学术论文:{{ zhichengxiangqing.pkmark || 0 }}篇
科普文章:{{ zhichengxiangqing.hxmark || 0 }}篇
职称要求查看来源
职称说明
以上信息,由域田数据科技根据网络公开资料自动分析生成,仅供参考!